Brief: Hofseth Biocare Q4 Operating Revenue Up At Nok 26.4 Million
Feb 15 (Reuters) - HOFSETH BIOCARE ASA HOFBC.OL :
* Q4 OPERATING REVENUE NOK 26.4 MILLION VERSUS NOK 3.1
MILLION
YEAR AGO
* Q4 EBITDA LOSS NOK 6.6 MILLION VERSUS LOSS NOK 12.9
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE8M4mVy
Further company coverage: HOFBC.OL
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering